Chart: Data compiled by the Rose Sheet from information in CIR reports following the Expert Panel's Sept. 11-12 meeting.
(a) Except Hydrolyzed Maple Sycamore Protein, which requires additional safety information
(b) When formulated to be non-sensitizing
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
EFSA is consulting on a provisional CBD safe dose of 2mg for a 70kg adult and has stated that the safety of CBD cannot be established for individuals under 25 years of age, pregnant or lactating women, and those on existing medications.
UK CBD food supplement applications from Chanelle McCoy, Cannaray Brands and the European Industrial Hemp Association pass FSA's safety assessment stage and are now out for consultation. After that, only government approval stands in their way, with five years exclusivity the icing on the cake.
Updating wastewater treatment facilities in Germany will cost almost three times more than the German Association of Local Public Utilities (VKU) has predicted, according to a Pharma Deutschland analysis.
A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.
The Expert Panel for Cosmetic Ingredient Safety maintains that it needs data that reflect real-world conditions when conducting its reviews, issuing an ‘insufficient conclusion’ for hair dye ingredient butoxyethanol.
Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.
FTC Bureau of Consumer Protection Director Chris Mufarrige says the commission is vigorously enforcing consumer and competition laws but will not assume a ‘broader delegation’ of authority than granted it by Congress.
